Literature DB >> 15586780

Effects of lesions of the histaminergic tuberomammillary nucleus on spontaneous sleep in rats.

Dmitry Gerashchenko1, Thomas C Chou, Carlos A Blanco-Centurion, Clifford B Saper, Priyattam J Shiromani.   

Abstract

STUDY
OBJECTIVES: Extensive evidence suggests that histaminergic neurons promote wakefulness. Histaminergic neurons are found exclusively in the tuberomammillary nucleus (TMN), and electrolytic lesions of the posterior hypothalamus, where the TMN resides, produce intense hypersomnolence. However, electrolytic lesions disrupt fibers of passage, and the effects of fiber-sparing, cell-specific TMN lesions on sleep and wakefulness are unknown. Hence, we placed cell-specific lesions in the TMN to determine its role in spontaneous wakefulness.
DESIGN: TMN neurons in rats are relatively resistant to excitotoxins. Hence, we ablated them using saporin conjugated to hypocretin 2, which ablates hypocretin receptor-bearing neurons such as TMN neurons. One to 2 weeks after bilateral injections of Hcrt2-SAP into Sprague-Dawley rats, we correlated loss of TMN neurons with changes in sleep.
SETTING: N/A. PARTICIPANTS: N/A.
INTERVENTIONS: N/A. MEASUREMENTS AND
RESULTS: Four days after injections with hypocretin-2-saporin, the number of TMN neurons was markedly decreased, and most were lost after 12 days, as determined by immunohistochemistry for adenosine deaminase, a marker of TMN neurons. Nearby nonhistaminergic neurons were similarly ablated. Rats with an average 82.5% loss of TMN cells (determined 2 weeks after injection) did not have marked changes in total sleep amounts compared to saline-treated rats 1 or 2 weeks following the injection, except for a slight decrease in rapid eye movement sleep during the lights-on period for the first week only. The percentage of remaining TMN neurons positively correlated with the average duration of wake bouts during the lights-off period.
CONCLUSION: The absence of gross changes in sleep after extensive loss of histaminergic neurons suggests that this system is not critical for spontaneous wakefulness.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15586780      PMCID: PMC1249486          DOI: 10.1093/sleep/27.7.1275

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  26 in total

Review 1.  The role of histamine and the tuberomamillary nucleus in the nervous system.

Authors:  Helmut Haas; Pertti Panula
Journal:  Nat Rev Neurosci       Date:  2003-02       Impact factor: 34.870

2.  Afferents to the ventrolateral preoptic nucleus.

Authors:  Thomas C Chou; Alvhild A Bjorkum; Stephanie E Gaus; Jun Lu; Thomas E Scammell; Clifford B Saper
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

3.  Effect of lesions of the ventrolateral preoptic nucleus on NREM and REM sleep.

Authors:  J Lu; M A Greco; P Shiromani; C B Saper
Journal:  J Neurosci       Date:  2000-05-15       Impact factor: 6.167

4.  Neurotoxic lesion of the mesencephalic reticular formation and/or the posterior hypothalamus does not alter waking in the cat.

Authors:  M Denoyer; M Sallanon; C Buda; K Kitahama; M Jouvet
Journal:  Brain Res       Date:  1991-01-25       Impact factor: 3.252

5.  Activation of ventrolateral preoptic neurons during sleep.

Authors:  J E Sherin; P J Shiromani; R W McCarley; C B Saper
Journal:  Science       Date:  1996-01-12       Impact factor: 47.728

6.  Hypocretin-2-saporin lesions of the lateral hypothalamus produce narcoleptic-like sleep behavior in the rat.

Authors:  D Gerashchenko; M D Kohls; M Greco; N S Waleh; R Salin-Pascual; T S Kilduff; D A Lappi; P J Shiromani
Journal:  J Neurosci       Date:  2001-09-15       Impact factor: 6.167

7.  H3 agonist immepip markedly reduces cortical histamine release, but only weakly promotes sleep in the rat.

Authors:  Yves Lamberty; Doru Georg Margineanu; Donald Dassesse; Henrik Klitgaard
Journal:  Pharmacol Res       Date:  2003-08       Impact factor: 7.658

8.  Sleep-waking discharge of neurons in the posterior lateral hypothalamus of the albino rat.

Authors:  T L Steininger; M N Alam; H Gong; R Szymusiak; D McGinty
Journal:  Brain Res       Date:  1999-09-04       Impact factor: 3.252

9.  Anatomical, physiological, and pharmacological characteristics of histidine decarboxylase knock-out mice: evidence for the role of brain histamine in behavioral and sleep-wake control.

Authors:  Régis Parmentier; Hiroshi Ohtsu; Zahia Djebbara-Hannas; Jean-Louis Valatx; Takehiko Watanabe; Jian-Sheng Lin
Journal:  J Neurosci       Date:  2002-09-01       Impact factor: 6.167

10.  Cataplexy-active neurons in the hypothalamus: implications for the role of histamine in sleep and waking behavior.

Authors:  Joshi John; Ming-Fung Wu; Lisa N Boehmer; Jerome M Siegel
Journal:  Neuron       Date:  2004-05-27       Impact factor: 17.173

View more
  28 in total

1.  Endogenous histamine facilitates long-term potentiation in the hippocampus during walking.

Authors:  Tao Luo; L Stan Leung
Journal:  J Neurosci       Date:  2010-06-09       Impact factor: 6.167

2.  Identification of wake-active dopaminergic neurons in the ventral periaqueductal gray matter.

Authors:  Jun Lu; Thomas C Jhou; Clifford B Saper
Journal:  J Neurosci       Date:  2006-01-04       Impact factor: 6.167

3.  Inability to replicate cerebrospinal fluid histamine deficits in the primary hypersomnias: a back to the drawing board moment.

Authors:  David B Rye
Journal:  Sleep       Date:  2012-10-01       Impact factor: 5.849

Review 4.  Control of sleep and wakefulness.

Authors:  Ritchie E Brown; Radhika Basheer; James T McKenna; Robert E Strecker; Robert W McCarley
Journal:  Physiol Rev       Date:  2012-07       Impact factor: 37.312

5.  Reassessing the Role of Histaminergic Tuberomammillary Neurons in Arousal Control.

Authors:  Anne Venner; Takatoshi Mochizuki; Roberto De Luca; Christelle Anaclet; Thomas E Scammell; Clifford B Saper; Elda Arrigoni; Patrick M Fuller
Journal:  J Neurosci       Date:  2019-09-23       Impact factor: 6.167

6.  The wake-promoting transmitter histamine preferentially enhances α-4 subunit-containing GABAA receptors.

Authors:  Matt T Bianchi; Alison G Clark; Janet L Fisher
Journal:  Neuropharmacology       Date:  2011-05-27       Impact factor: 5.250

7.  Decreased CSF histamine in narcolepsy with and without low CSF hypocretin-1 in comparison to healthy controls.

Authors:  Seiji Nishino; Eiko Sakurai; Sona Nevsimalova; Yasushi Yoshida; Takehiko Watanabe; Kazuhiko Yanai; Emmanuel Mignot
Journal:  Sleep       Date:  2009-02       Impact factor: 5.849

8.  Role of Basal Ganglia in sleep-wake regulation: neural circuitry and clinical significance.

Authors:  Ramalingam Vetrivelan; Mei-Hong Qiu; Celene Chang; Jun Lu
Journal:  Front Neuroanat       Date:  2010-11-23       Impact factor: 3.856

9.  Effects of saporin-induced lesions of three arousal populations on daily levels of sleep and wake.

Authors:  Carlos Blanco-Centurion; Dmitry Gerashchenko; Priyattam J Shiromani
Journal:  J Neurosci       Date:  2007-12-19       Impact factor: 6.167

10.  Hypocretin-2 saporin lesions of the ventrolateral periaquaductal gray (vlPAG) increase REM sleep in hypocretin knockout mice.

Authors:  Satvinder Kaur; Stephen Thankachan; Suraiya Begum; Meng Liu; Carlos Blanco-Centurion; Priyattam J Shiromani
Journal:  PLoS One       Date:  2009-07-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.